Class of HDAC inhibitors expands the renal progenitor cells population and improves the rate of recovery from acute kidney injury
US10233201B2 · kind B2 · utility
0Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 2017 |
| Grant date | Mar 19, 2019 |
| Priority date | — |
| Expiry date | May 30, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/5325
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds and compositions are provided that inhibit histone deacylase activity and which expand renal progenitor cell populations and improve kidney function in a damaged kidney. Methods of use of the compounds and compositions are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.